Q1 22 LFL comes short due to contract phasing in non-nuclear Q1 22 sales came in at EUR125m up 9.2%, of which 2.3% was LFL. We were expecting sales of EUR122m and organic growth at 5.1%. The shortfall to our forecasts was mainly due to the non-nuclear business. Nuclear sales were up 6.3%, consistent with our estimates and driven by good level of activity in France and the UK. The non-nuclear business saw a stronger contribution from MandA but lower organic growth (-6.6%) due to unfavourable ph ....